Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FPAQH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,169.59 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on June 16, 2025, for the supply of 120 tablets of Xtandi 40 mg, an oncology medication used primarily in prostate cancer treatment. The contract, which must be completed by June 17, 2025, carries no set-aside designation and will be performed at the contractor's facility in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler established in 2001, was selected as the awardee based on its established capabilities and pricing.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The underlying IDC authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain through consistent performance on similar delivery orders covering oncology treatments, specialty medications, and other prescription drugs supporting military health operations.
Quick answers
Who was awarded contract SPE2DB25FPAQH?
SPE2DB25FPAQH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 16, 2025.
How much is contract SPE2DB25FPAQH worth?
The government has obligated $4,170 on SPE2DB25FPAQH.
Is contract SPE2DB25FPAQH an order under another contract?
Yes. SPE2DB25FPAQH is a delivery order under SPE2DB25D9336, an indefinite delivery contract.
Was contract SPE2DB25FPAQH competed?
The extent of competition for SPE2DB25FPAQH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award